focus -WSS

focus

author：entertainment 2025-09-06 01:58:48 - browse：16

Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth has made it easy to schedule a virtual visit and get a script, sometimes within minutes, with prescriptions shipped to your doorstep.

Now, Big Pharma is ready to get in on the action.

In early January, Eli Lilly announced a platform that allows patients to access and fill prescriptions for its drugs online, timing the news to the availability of its obesity medication Zepbound. Using LillyDirect, patients click into a pipeline for their condition — obesity, diabetes, or migraine — and are routed to telehealth sites that can prescribe them one of Lilly’s drugs if they’re eligible. An integration with online pharmacy Truepill will deliver the meds.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

WSS

Apple Vision Pro: A first look at health apps on the new VR headset

'Revelatory' study finds a smoking impact that remains after quitting

BioAge raises $170M for combination therapy with Zepbound

Quicker fix for pulse oximeters urged during FDA public meeting

Medicare threatens to cut off funding for HCA's Mission hospital

Medicare threatens to cut off funding for HCA's Mission hospital

leisure time

focus

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The Readout: Gilead, Bernie Sanders, and other pharma news

Novavax promises a turnaround & Lilly roils the obesity market

Doctors' information doesn't help them choose wisely when sick

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare drug price negotiation’s day in court

Activists slam private health insurers over coverage restrictions

Even great ERs can’t make up for American health disparities

Medical leaders decry Supreme Court decision on affirmative action

Private equity deals in Medicare Advantage declines

focus

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Commercial surrogacy can be ethical, despite pope’s claims

'Revelatory' study finds a smoking impact that remains after quitting

The lessons of Aduhelm, an Alzheimer's drug that was not to be

BioAge raises $170M for combination therapy with Zepbound

Vaccine advisory panel ACIP left half staffed by HHS

leisure time

focus

entertainment

focus